Literature DB >> 11580926

Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern Turkey.

G Attila1, E Acartürk, G Eskandari, O Akpinar, A Tuli, M KanadaşI, L Kayrin.   

Abstract

BACKGROUND: Apolipoprotein E (apoE) plays a major role in lipoprotein metabolism and lipid transport. Associations between apoE genotypes, coronary artery disease (CAD) and other risk factors have been described by many investigators. The aim of this study was to investigate the role of apoE gene polymorphism and other risk factors in the development of CAD in subjects whose coronary arteries were evaluated by means of coronary angiography.
METHODS: The study population consisted of 199 subjects (114 male and 55 female). Of the total, 107 had CAD. The apoE gene was amplified by polymerase chain reaction (PCR) and then digested by CfoI restriction enzyme. The plasma lipid levels and other risk factors were also determined in all subjects.
RESULTS: The epsilon2 and epsilon4 allele frequencies and genotypes carrying epsilon4 allele were significantly higher in CAD (+) patients. Plasma lipids except triglycerides were increased in CAD (+) cases. We found that apoE genotypes, HT, DM, male gender, age and smoking were the independent predictors of CAD. There was no association between apoE alleles and lipids.
CONCLUSION: We conclude that apoE polymorphism (presence of epsilon4 allele) is associated with the development of CAD in Southern Turkey. In our study, we did not observe any effect of apoE alleles on lipid levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11580926     DOI: 10.1016/s0009-8981(01)00624-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Association between apolipoprotein ε4 allele, factor V Leiden, and plasma lipid and lipoprotein levels with sickle cell disease in Southern Iran.

Authors:  Zohreh Rahimi; Asad Vaisi-Raygani; Tayebeh Pourmotabbed
Journal:  Mol Biol Rep       Date:  2010-04-07       Impact factor: 2.316

2.  The Distribution of Apolipoprotein E Gene Polymorphism and Apolipoprotein E Levels among Coronary Artery Patients Compared to Controls.

Authors:  Omer Atis; Semsettin Sahin; Koksal Ceyhan; Huseyin Ozyurt; Ali Akbas; Ismail Benli
Journal:  Eurasian J Med       Date:  2016-06

3.  Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins.

Authors:  Ping Lv; Yaofu Zheng; Jun Huang; Junsong Ke; Hongyu Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-10-23       Impact factor: 2.570

4.  Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease.

Authors:  Rajesh Chaudhary; Atip Likidlilid; Thavatchai Peerapatdit; Damras Tresukosol; Sorachai Srisuma; Suphachai Ratanamaneechat; Charn Sriratanasathavorn
Journal:  Cardiovasc Diabetol       Date:  2012-04-23       Impact factor: 9.951

Review 5.  Apolipoprotein E Gene Variants and Risk of Coronary Heart Disease: A Meta-Analysis.

Authors:  Min Xu; Jun Zhao; Yu Zhang; Xu Ma; Qiaoyun Dai; Hong Zhi; Bei Wang; Lina Wang
Journal:  Biomed Res Int       Date:  2016-10-27       Impact factor: 3.411

6.  Relation between Apolipoprotein E Gene Polymorphism and Severity of Coronary Artery Disease in Acute Myocardial Infarction.

Authors:  Zülküf Karahan; Murat Uğurlu; Berzal Uçaman; Ali Veysel Uluğ; İlyas Kaya; Kemal Çevik; Önder Öztürk; Hikmet Iyem
Journal:  Cardiol Res Pract       Date:  2015-08-24       Impact factor: 1.866

7.  Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease.

Authors:  Dalia El-Lebedy; Hala M Raslan; Asmaa M Mohammed
Journal:  Cardiovasc Diabetol       Date:  2016-01-22       Impact factor: 9.951

8.  Endothelial nitric oxide synthase Glu 298 Asp (G894T) and Apolipoprotein E gene polymorphism as possible risk factors for coronary heart disease among Egyptians.

Authors:  Sherif Arafa; Sherehan Abdelsalam; Abdel-Hady El-Gilany; Youssef Mohamed Mosaad; Adel Abdel-Ghaffar
Journal:  Egypt Heart J       Date:  2018-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.